Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL‐receptor gene mutation

Mutations within the low density lipoprotein (LDL)‐receptor gene result in familial hypercholesterolemia, an autosomal dominant inherited disease. Clinical homozygous affected subjects die of premature coronary artery disease as early as in early childhood. We identified a girl at the age of five yr with clinical homozygous familial hypercholesterolemia presenting with achilles tendon xanthomas and arcus lipoides. Her total cholesterol reached up to 1050 mg/dL. Molecular characterization of the LDL‐receptor gene revealed a homozygous p.W577R mutation. Despite intensive treatment interventions with the combination of diet, statins, colestipol, and LDL‐apheresis, the patient developed symptomatic coronary artery disease at the age of 16 yr. Subsequently, orthotopic liver transplantation was performed to cure the defective LDL‐receptor gene. Clinical follow‐up for almost nine yr post‐transplantation revealed excellent liver function, normal liver enzymes, normal LDL‐cholesterol, and regression of both tendon xanthomas and symptomatic coronary artery disease. In conclusion, liver transplantation can effectively reduce LDL‐cholesterol in a familial hypercholesterolemia recipient with subsequent regression of xanthomas and atherosclerosis. Timing is extremely important in these exceptional cases to exclude the demand for heart transplantation due to severe coronary artery disease. In addition, the identification of the LDL‐receptor as etiology of clinical homozygous hypercholesterolemia is a prerequisite once liver transplantation is considered as therapeutic option.

[1]  G. Dedoussis,et al.  LDL‐receptor mutations in Europe , 2004, Human mutation.

[2]  N. Heaton,et al.  Successful living-related liver transplantation for familial hypercholesterolemia in the Middle East , 2004, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  W. Uckert,et al.  Non‐physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage , 2004, The journal of gene medicine.

[4]  G. Klintmalm,et al.  Xanthomas disappear rapidly after liver transplantation for familial hypercholesterolemia , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  I. Popescu,et al.  Homozygous familial hypercholesterolemia: specific indication for domino liver transplantation , 2003, Transplantation.

[6]  P. Toutouzas,et al.  Molecular characterization of familial hypercholesterolemia in German and Greek patients , 2003 .

[7]  E. Schrumpf,et al.  Plasma exchange and heart–liver transplantation in a patient with homozygous familial hypercholesterolemia , 2001, Clinical transplantation.

[8]  R. Burger,et al.  Complement activation by recombinant adenoviruses , 2001, Gene Therapy.

[9]  Hyesung Jeon,et al.  Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair , 2001, Nature Structural Biology.

[10]  T. Springer,et al.  An extracellular beta-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components. , 1998, Journal of molecular biology.

[11]  F. Berr,et al.  IMAGES IN HEPATOLOGY , 1998 .

[12]  M. Manns,et al.  Images in hepatology. Regression of xanthelasmas in a patient with primary biliary cirrhosis after liver transplantation. , 1998, Journal of hepatology.

[13]  R. Havel,et al.  Gene therapy for cholesterol , 1994, Nature Genetics.

[14]  James M. Wilson,et al.  Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity. , 1992, Human gene therapy.

[15]  J. Wilson,et al.  Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. , 1991, Science.

[16]  R. Mulligan,et al.  Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Starzl,et al.  Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia. , 1987, The American journal of cardiology.

[18]  S. Grundy,et al.  Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation. , 1986, Journal of the American Medical Association (JAMA).

[19]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[20]  S. Grundy,et al.  Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. , 1984, The New England journal of medicine.

[21]  Manfred Stuhrmann,et al.  LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis , 1998, Nucleic Acids Res..

[22]  H. Hobbs,et al.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia , 1992, Human mutation.

[23]  T. Farag,et al.  Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.